These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


236 related items for PubMed ID: 22778055

  • 1. Positron-emission tomography pitfalls related to oral prosthesis.
    More Y, Dusing R, Counts S, Bond J, Tsue T, Girod D.
    Laryngoscope; 2013 Feb; 123(2):404-6. PubMed ID: 22778055
    [Abstract] [Full Text] [Related]

  • 2. Three-Dimensional Image Fusion of 18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography and Contrast-Enhanced Computed Tomography for Computer-Assisted Planning of Maxillectomy of Recurrent Maxillary Squamous Cell Carcinoma and Defect Reconstruction.
    Yu Y, Zhang WB, Liu XJ, Guo CB, Yu GY, Peng X.
    J Oral Maxillofac Surg; 2017 Jun; 75(6):1301.e1-1301.e15. PubMed ID: 28320612
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
    Han D, Yu J, Zhong X, Fu Z, Mu D, Zhang B, Xu G, Yang W, Zhao S.
    Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
    [Abstract] [Full Text] [Related]

  • 4. Clinical values of (18) F-FDG PET/CT in oral cavity cancer with dental artifacts on CT or MRI.
    Hong HR, Jin S, Koo HJ, Roh JL, Kim JS, Cho KJ, Choi SH, Nam SY, Kim SY.
    J Surg Oncol; 2014 Nov; 110(6):696-701. PubMed ID: 24995957
    [Abstract] [Full Text] [Related]

  • 5. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
    Roh JL, Park JP, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
    [Abstract] [Full Text] [Related]

  • 6. Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumors.
    Abramyuk A, Wolf G, Shakirin G, Haberland U, Tokalov S, Koch A, Appold S, Zöphel K, Abolmaali N.
    Acta Radiol; 2010 Sep; 51(7):793-9. PubMed ID: 20583948
    [Abstract] [Full Text] [Related]

  • 7. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.
    Schwartz DL, Ford E, Rajendran J, Yueh B, Coltrera MD, Virgin J, Anzai Y, Haynor D, Lewellyn B, Mattes D, Meyer J, Phillips M, Leblanc M, Kinahan P, Krohn K, Eary J, Laramore GE.
    Int J Radiat Oncol Biol Phys; 2005 Jan 01; 61(1):129-36. PubMed ID: 15629603
    [Abstract] [Full Text] [Related]

  • 8. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD, Carlson ER, Heidel RE.
    J Oral Maxillofac Surg; 2015 Jul 01; 73(7):1420-8. PubMed ID: 25869746
    [Abstract] [Full Text] [Related]

  • 9. FDG-PET/CT in staging of clear cell odontogenic carcinoma.
    Krishnamoorthy R, Ravi Kumar AS, Batstone M.
    Int J Oral Maxillofac Surg; 2014 Nov 01; 43(11):1326-9. PubMed ID: 25015905
    [Abstract] [Full Text] [Related]

  • 10. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.
    Interact Cardiovasc Thorac Surg; 2010 Jun 01; 10(6):1009-14. PubMed ID: 20197344
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma.
    Koyasu S, Nakamoto Y, Kikuchi M, Suzuki K, Hayashida K, Itoh K, Togashi K.
    AJR Am J Roentgenol; 2014 Apr 01; 202(4):851-8. PubMed ID: 24660716
    [Abstract] [Full Text] [Related]

  • 12. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
    Ozkan E, Soydal C, Kucuk ON, Ibis E, Erbay G.
    Nucl Med Commun; 2011 Dec 01; 32(12):1162-8. PubMed ID: 21946617
    [Abstract] [Full Text] [Related]

  • 13. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
    Dennis K, Hay JH, Wilson DC.
    Clin Oncol (R Coll Radiol); 2012 Dec 01; 24(10):e168-72. PubMed ID: 22944464
    [Abstract] [Full Text] [Related]

  • 14. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S, Schmidt H, Gücke B, Bezrukov I, Seitz G, Ebinger M, Reimold M, Pfannenberg CA, Nikolaou K, Schwenzer NF, Schäfer JF.
    Invest Radiol; 2016 Jan 01; 51(1):7-14. PubMed ID: 26309185
    [Abstract] [Full Text] [Related]

  • 15. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H, Henderson RW, Conti PS.
    J Comput Assist Tomogr; 2007 Jan 01; 31(2):223-8. PubMed ID: 17414758
    [Abstract] [Full Text] [Related]

  • 16. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH, Yen TC, Chang JT, Chan SC, Ko SF, Wang HM, Lee LY, Kang CJ, Wong AM, Liao CT.
    J Clin Oncol; 2006 Sep 20; 24(27):4371-6. PubMed ID: 16983105
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic value of only 18F-fluorodeocyglucose positron emission tomography/computed tomography-positive lymph nodes in head and neck squamous cell carcinoma.
    Lee SH, Huh SH, Jin SM, Rho YS, Yoon DY, Park CH.
    Otolaryngol Head Neck Surg; 2012 Oct 20; 147(4):692-8. PubMed ID: 22535915
    [Abstract] [Full Text] [Related]

  • 18. Comparison between 2-(18) F-fluoro-2-deoxy-d-glucose positron emission tomography and contrast-enhanced computed tomography for measuring gross tumor volume in cats with oral squamous cell carcinoma.
    Yoshikawa H, Randall EK, Kraft SL, Larue SM.
    Vet Radiol Ultrasound; 2013 Oct 20; 54(3):307-13. PubMed ID: 23441633
    [Abstract] [Full Text] [Related]

  • 19. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
    Lee DY, Lee CH, Seo MJ, Lee SH, Ryu JS, Lee JJ.
    Ann Nucl Med; 2014 Oct 20; 28(8):789-95. PubMed ID: 24965850
    [Abstract] [Full Text] [Related]

  • 20. Incidental focal colonic lesions found on (18)Fluorodeoxyglucose positron emission tomography/computed tomography scan: further support for a national guideline on definitive management.
    Farquharson AL, Chopra A, Ford A, Matthews S, Amin SN, De Noronha R.
    Colorectal Dis; 2012 Feb 20; 14(2):e56-63. PubMed ID: 21831171
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.